Submit your manuscript directly to exarjournal@yahoo.com
Excellence in Autoantibody Research (EXAR)
Instructions for authors
Excellence in Autoantibody Research (EXAR) publishes articles on all aspects of autoantibody research. The journal provides current research information on basic, translational and advanced autoimmunity relevant to autoantibodies.
The Journal is an Edition of the Institute of Rheumatic and Autoimmune Diseases (INRADIS). INRADIS is dedicated to publish and provide access to quality information and valuable contributions to the journal’s respective field. It follows a specific format for each article type to the credit of weight in the information and maintains diverse appearance for reader’s convenience. Therefore the authors will be guided to meet the submission criteria of corresponding article type with the author’s responsibilities and manuscript preparation and submission.
More information on journal policies is available on ‘About‘ page
Excellence in Autoantibody Research (EXAR) publishes all types of articles such as:
– Original
– Review
– Editorial
– Expert Opinion
– Technical or Educational Note,
– Case Study
– Letter to The Editor
– Image
Once a manuscript has completed the peer review process, the Editor will forward review reports from the Reviewers and the Author may be asked for major or minor corrections for further quality development in the manuscript.
Please follow the guidelines below and crosscheck to ensure that the edited MS is better understanding by the Editor and Reviewers.
The revised manuscript must have a cover letter outlining all the changes that have been made in response to the reviewer’s comments/criticisms.
Highlight by the use of colored text or use Track Changes to the newly modified or added text.
Ensure that the files are saved in .Doc (MS Word) or PDF format only.
Provide a complete Figure Legend for each figure
Make sure that the citations are placed in Vancouver style, only by the Reference Number in parentheses. Eg., (1, 2-3)
Check that you have mentioned your Conflict of Interest, Authors Contributions and Acknowledgements.